HEALTHCARE TRUST OF AME-CL A (HTA) Forecast, Price Target & Analyst Ratings

NYSE:HTA • US42225P5017

Current stock price

29.19 USD
-0.02 (-0.07%)
At close:
29.23 USD
+0.04 (+0.14%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEALTHCARE TRUST OF AME-CL A (HTA).

Forecast Snapshot

Consensus Price Target

Price Target
$33.72
+ 15.53% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 5, 2022
Period
Q2 / 2022
EPS Estimate
$0.09
Revenue Estimate
200.536M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
71.43%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$33.72
Upside
+ 15.53%
From current price of $29.19 to mean target of $33.72, Based on 14 analyst forecasts
Low
$28.28
Median
$35.19
High
$38.33

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for HTA. The average price target is 33.72 USD. This implies a price increase of 15.53% is expected in the next year compared to the current price of 29.19.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

HTA Current Analyst RatingHTA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

HTA Historical Analyst RatingsHTA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
71.43%
HTA was analyzed by 14 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about HTA.
In the previous month the buy percentage consensus was at a similar level.
HTA was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-05-10BerenbergUpgrade Hold -> Buy
2022-02-01Credit SuisseInitiate Outperform
2021-11-24BerenbergDowngrade Buy -> Hold
2021-09-30Truist SecuritiesDowngrade Buy -> Hold
2021-08-20Raymond JamesDowngrade Outperform -> Market Perform
2021-08-04BMO CapitalDowngrade Outperform -> Market Perform
2021-04-08SMBC NikkoDowngrade Outperform -> Neutral
2021-03-15Morgan StanleyMaintains Equal-Weight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 5, 2022
Period
Q2 / 2022
EPS Estimate
$0.09
Revenue Estimate
200.536M
Revenue Q2Q
6.32%
EPS Q2Q
-46.53%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

HTA is expected to report earnings on 8/5/2022. The consensus EPS estimate for the next earnings is 0.09 USD and the consensus revenue estimate is 200.54M USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2022 - 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
HTA revenue by date.HTA revenue by date.
692M
-0.63%		739M
6.79%		767.07M
3.80%		822.5M
7.23%		843.127M
2.51%		884.147M
4.87%		907.665M
2.66%		941.126M
3.69%
EBITDA
YoY % growth
HTA ebitda by date.HTA ebitda by date.
429.8M
-0.58%		448.3M
4.30%		459.95M
2.60%		524.007M
13.93%		550.168M
4.99%		560.968M
1.96%		574.729M
2.45%		594.717M
3.48%
EBIT
YoY % growth
HTA ebit by date.HTA ebit by date.
148.8M
-7.52%		165.3M
11.09%		176.65M
6.87%		195.909M
10.90%		212.836M
8.64%		226.173M
6.27%		240.625M
6.39%		258.559M
7.45%
Operating Margin
HTA operating margin by date.HTA operating margin by date.
21.50%22.37%23.03%23.82%25.24%25.58%26.51%27.47%
EPS
YoY % growth
HTA eps by date.HTA eps by date.
0.24
9.09%		0.240.44
83.33%		0.42
-3.59%		0.47
10.32%		0.55
16.55%		0.61
12.31%		0.69
13.43%

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 22 Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		0.09
-46.53%		0.10
1.00%		0.10
44.29%		0.10
26.25%		0.10
11.11%		0.100.10
Revenue
Q2Q % growth		200.536M
6.32%		201.596M
5.40%		201.142M
2.78%		208.435M
3.19%		209.3M
4.37%		213.275M
5.79%		214.127M
6.46%
EBITDA
Q2Q % growth		128.472M
-31.43%		128.775M
-49.93%		130.189M
-59.90%		135.138M
13.29%		136.401M
6.17%		139.027M
7.96%		140.39M
7.84%
EBIT
Q2Q % growth		51.999M
14.79%		51.584M
14.94%		52.492M
26.79%		53.564M
10.95%		54.558M
4.92%		55.575M
7.74%		56.609M
7.84%

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HTA Yearly Revenue VS EstimatesHTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
HTA Yearly EPS VS EstimatesHTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
7.42%
EPS Next 5 Year
9.57%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
4.63%
Revenue Next 5 Year
4.05%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HEALTHCARE TRUST OF AME-CL A / HTA Forecast FAQ

What is the average price target for HEALTHCARE TRUST OF AME-CL A (HTA) stock?

14 analysts have analysed HTA and the average price target is 33.72 USD. This implies a price increase of 15.53% is expected in the next year compared to the current price of 29.19.

Can you provide the upcoming earnings date for HEALTHCARE TRUST OF AME-CL A?

HEALTHCARE TRUST OF AME-CL A (HTA) will report earnings on 2022-08-05, after the market close.

Can you provide the consensus estimates for HEALTHCARE TRUST OF AME-CL A next earnings?

The consensus EPS estimate for the next earnings of HEALTHCARE TRUST OF AME-CL A (HTA) is 0.09 USD and the consensus revenue estimate is 200.54M USD.

What is the consensus rating for HEALTHCARE TRUST OF AME-CL A (HTA) stock?

The consensus rating for HEALTHCARE TRUST OF AME-CL A (HTA) is 71.4286 / 100 . This indicates that analysts generally have a positive outlook on the stock.